Latest News
From the Journals
Don’t choose hormones to protect postmenopausal women
The USPSTF has issued a recommendation against using estrogen or estrogen plus progestin to prevent chronic conditions in postmenopausal women.
Conference Coverage
Extra years of adjuvant bisphosphonate not needed in early breast cancer
SAN ANTONIO - Neither adapted disease-free survival nor overall survival were significantly better with 3 extra years of zoledronate therapy.
Conference Coverage
Shift to long-term ‘maternal care’ needs boost
WASHINGTON – “We need regular screening of women” to prevent long-term metabolic and cardiovascular disorders, said Dr. George R. Saade.
Video
MACRA Monday: BMI screening and follow-up
Calculating one patient’s BMI and developing a follow-up plan could help you avoid a 4% MIPS penalty.
Conference Coverage
VIDEO: Novel PARP inhibitor boosts PFS in HER2– breast cancer with BRCA mutations
From the Journals
Obesity an independent risk factor for rosacea in cohort study of U.S. women
Previous epidemiologic studies examining the interaction between obesity and rosacea have shown inconsistent results.
Conference Coverage
VIDEO: Weight loss cut risk of breast cancer
SAN ANTONIO – Women in the Women’s Health Initiative Observational Study who lost at least 5% of their body weight had a significant 12% reduction...
Conference Coverage
2 = 5 for additional AI therapy for postmenopausal HR+ breast cancer
SAN ANTONIO - Five years of additional therapy with anastrozole was no more effective than 2 additional years.
News from the FDA/CDC
Health disparities in rural America: Chronic conditions
Black and American Indian/Alaska Native adults most likely to have multiple chronic health conditions.
Conference Coverage
Shaping practice: Z1071 continues to redefine axillary management
SAN DIEGO – The Z1071 landmark study proves the safety of leaving the axilla intact in node-positive patients who respond well to neoadjuvant...
Feature
Clinical trial: Study underway of robot-assisted surgery for pelvic prolapse
Sacrocolpopexy is the focus of a trial examining robotic assisted–procedure learning curves and outcomes.